China: Study On Foreign-Invested Medical Institutions (I): Policies

Last Updated: 26 January 2017
Article by Huanhao He and Ruina Liu

Can foreign investors set up wholly-owned medical institutions in China? This is a question that clients constantly ask when entering the Chinese healthcare industry, and this question is even more complicated when it comes to specific cases. We therefore intend to analyze this issue in terms of regulatory policy and practice by drawing on our experience in assisting multiple foreign institutions to make investments in the domestic healthcare industry. This article is the first of two and will focus on policy analysis.

The PRC government's policies for foreign investment in domestic medical institutions have consistently changed over time. Initially, the PRC government tended to restrict foreign capital from entering the domestic medical industry. At the end of 2010, these restrictions had begun to be relaxed. In 2015, however, the government again tightened its control over foreign investment in domestic medical institutions. These three stages of the PRC government's position towards foreign investment are roughly shown in the following chart:

"Foreign investors" includes investors outside of China and also investors in Taiwan, Hong Kong and Macao. PRC laws and regulations related to the admission of foreign investment ordinarily apply to foreign investors and then cite applicability to Taiwan, Hong Kong, and Macao. In this case, however, policies related to foreign investment in the healthcare industry not only contain general rules applicable to foreign investors, but also some special rules that are only applicable to Taiwan, Hong Kong and Macao investors.

Foreign Investors –Bad News, Good News and Bad News Again

Foreign capital began entering PRC medical institutions in the late 1980s. As the reform and opening up deepened, domestic medical and healthcare services become inadequate to meet the growing needs of foreigners. On February 10, 1989, the former Ministry of Health and former Ministry of Foreign Trade and Economic Cooperation jointly promulgated the Several Provisions on the Establishment of Hospitals or Clinics by Foreigners or Overseas Chinese and the Medical Practice in China by Foreign Doctors (expired), which stipulated that overseas Chinese were permitted to establish one or two wholly-owned non-profit pilot hospitals or clinics and foreigners and overseas Chinese were permitted to establish one or two pilot Sino-foreign joint ventures or contractual hospitals or clinics. In each case, approvals should be obtained from the Ministry of Health and Ministry of Foreign Trade and Economic Cooperation. This is a prologue to establishing foreign-invested medical institutions in China.

Following these policies, the government expressly prohibited the establishment of wholly foreign-owned medical institutions for a significant period. The Interim Measures for the Administration of Chinese-foreign Equity Joint and Cooperative Joint Medical Institutions (order of Ministry of Health and Ministry of Foreign Trade and Economic Cooperation, [2000] No. 11, hereinafter referred to as "Interim Measures"), effective as of July 1, 2000, set forth that foreign investors were only permitted to establish medical institutions in the form of a joint venture or contractual business, and required the domestic shareholding in such investments to be no less than 30%.Catalogue for the Guidance of Foreign Investment Industries (revised in 1997) categorized medical institutions as restricted industry and expressly stipulated that domestic shareholders should have control over such institutions. Catalogue for the Guidance of Foreign Investment Industries (revised in 2002) still categorized medical institutions as restricted industry but deleted the domestic shareholder control requirement so as to avoid conflicting with the Interim Measures.

In November 2010, Circular of the General Office of the State Council on Forwarding the Opinions of the National Development and Reform Commission, the Ministry of Health and Other Departments on Further Encouraging and Guiding Non-government Funding for Medical Institutions (Guo Ban Fa [2010] No. 58) proposed the opening up of medical institutions and categorizing medical institutions as permitted industry. The circular stipulated the phasing out of foreign investor shareholding restrictions in medical institutions and to launch a pilot project for qualified foreign investors to establish wholly foreign-owned medical institutions in China. Subsequently, on January 30, 2012, the Catalogue for the Guidance of Foreign Investment Industries (Revised in 2011)was promulgated, which also categorized medical institutions as permitted to foreign investment. On November 13, 2013, Provisional Measures on the Administration of Wholly Foreign-Owned Medical Institutions in the China (Shanghai) Pilot Free Trade Zone was entered into force, which expressly stipulated that foreign investors were permitted to establish wholly foreign-owned medical institutions in Shanghai pilot free trade zone. Subsequently, on July 25, 2014, the National Health and Family Planning Commission ("NHFPA") and the Ministry of Commerce ("MOFCOM") jointly promulgated the Circular on Carrying out the Pilot Program for the Establishment of Wholly Foreign-Owned Hospitals (Guo Wei Yi Han [2014] No. 244, hereinafter referred to as "Circular 244"), expressly stipulating that foreign investors may establish wholly foreign-owned hospitals through greenfield investment, merger or acquisition in Beijing, Tianjin, Shanghai, Jiangsu, Fujian, Guangdong and Hainan ("Seven Pilot Provinces/Municipalities").

This period of opening up, however, did not last long. On April 10, 2015,Catalogue for the Guidance of Foreign Investment Industries (Revised in 2015)was implemented, and again categorized medical institutions as restricted industry and stipulated that foreign-invested medical institutions may only operate in the form of a joint venture or cooperative. On April 8, 2015, the General Office of the State Council promulgated the Circular on Issuing the Special Administrative Measures (Negative List) for Foreign Investment Access to Pilot Free Trade Zones, effective since May 8, 2015, which also categorizes medical institutions as restricted industry. Since the negative list is applicable to the free trade zones in Shanghai, Guangdong, Tianjin and Fujian, this meant the end of the policy permitting the establishment of wholly foreign-owned medical institutions in the Shanghai free trade zone.

Since Circular 244 has not yet been formally abolished, does this mean wholly foreign-owned hospitals are still allowed to be established in the Seven Pilot Provinces/Municipalities? We are afraid that the answer should be no.

  • First of all, in terms of legal provisions, Circular 244 was promulgated based upon the Catalogue for the Guidance of Foreign Investment Industries (Revised in 2011), which categorized medical institutions as permitted industry. Since the Catalogue has been further revised and the updated version has been approved by the State Council, the Circular 244 pilot program has lost its policy and legislative foundation.
  • Secondly, in terms of practical operations, we consulted with certain competent provincial and municipal healthcare and commercial administrations who also believe the new policy supersedes the Circular 244 pilot program.
  • Of course, strictly speaking, there should be no direct conflict between the old and new laws. We recommend that the government resolve this conflict as soon as possible.

Considering that the Catalogue for the Guidance of Foreign Investment Industries (Revised in 2015) significantly reduces restricted categories and relaxes restrictions on the foreign investor shareholding ratio in multiple industries, the categorization of medical institutions as restricted industry again causes us to believe that the authorities are unlikely to permit foreign investors to establish wholly foreign–owned medical institutions in China in the near future.

On September 3, 2016, the Standing Committee amended the Law of the People's Republic of China on Wholly Foreign-owned Enterprises and other three laws, stipulating that the establishment of foreign-invested enterprises that are not subject to special State admission management rules shall be subject to a filing rather than approval process. The State Council is to formulate or approve the special admission management rules, and the decision will become effective October 1, 2016. It remains to be seen whether the special rules will repeat the relevant provisions in the Catalogue for the Guidance of Foreign Investment Industries or instead provide a new national negative list based upon the existing free trade zone list.

Special Treatment for Taiwan, Hong Kong and Macao Investors

Compared with foreign investors, Taiwan, Hong Kong and Macao investors appear to enjoy more preferential policies in relation to investing or establishing medical institutions in mainland China:

  • On January 1, 2009, Supplementary Provisions II to the Interim Measures for the Administration of Sino-foreign Equity Joint Venture Medical Institutions and Sino-foreign Contractual Joint Venture Medical Institutions (Order of Ministry of Health and Ministry of Commerce No. 61) was put into force, which expressly stipulated that Hong Kong and Macao service providers were permitted to set up wholly foreign-owned clinics in Guangdong without restrictions as to the total investment amount.
  • According to Mainland-Hong Kong Closer Economic Partnership Arrangement and Mainland-Macao Closer Economic Partnership Arrangement ("CEPA"), NHFPA and MOFCOM jointly promulgated the Tentative Measures for Administration of Foundation of Wholly-Controlled Hospitals in Mainland China by Hong Kong and Macao Service Providers (Wei Yi Zheng Fa [2010] No. 109, the "Circular 109"), stipulating that Hong Kong and Macao service providers may set up wholly foreign-owned hospitals in Shanghai, Fujian, Guangdong, Hainan and Chongqing. The permitted regions shall expand to all municipalities directly under the Central Government and provincial capital cities since April 1, 2012.
  • According to the Cross-strait Economic Cooperation Framework Agreement("ECFA"), NHFPA and MOFCOM also jointly promulgated Tentative Measures for Administration of Foundation of Wholly-Controlled Hospitals in Mainland China by Taiwan Service Providers (Wei Yi Zheng Fa [2010] No. 110, the "Circular 110"), stipulating that Taiwan service providers may set up wholly foreign-owned hospitals in Shanghai, Jiangsu, Fujian, Guangdong and Hainan beginning on January 1, 2011.
  • On December 30, 2013, NHFPA and State Administration of Traditional Chinese Medicine jointly promulgated the Several Opinions on Accelerating the Operations of Medical Institutions with Social Capital (Guo Wei Ti Gai Fa [2013] No.54), which stipulated that Taiwan, Hong Kong and Macao service providers may establish wholly foreign-owned hospitals and expand to all cities at or above the prefectural level in China, provided that the approvals of the provincial health departments are obtained. The application of the regulation is also subject to local restrictions.

Pursuant to above policies, on December 13, 2011, the first wholly Taiwan-owned hospital, Landseed International Hospital, was founded in Shanghai. On January 1, 2013, the first wholly Hong Kong-owned hospital, C-MER (Shenzhen) Dennis Lam Eye Hospital, was founded in Shenzhen, Guangdong.

Unlike the situation in the Seven Pilot Provinces/Municipalities, the Catalogue for the Guidance of Foreign Investment Industries (Revised in 2015) expressly stipulates that "if there are other provisions in the CEPA, ECFA and the supplementary agreements, and the free trade zone agreements or investment agreements concluded and signed by and between China and other relevant countries, such provisions shall prevail." Therefore, we can infer that the establishment of wholly foreign-owned medical institutions by Taiwan, Hong Kong and Macao investors will not be affected by the new policies.

Summary of Policies related to Foreign-invested Medical Institutions

In summary, except for Taiwan, Hong Kong and Macao investors, foreign investors are currently prohibited from establishing wholly foreign-owned hospitals nationwide (including in free trade zones and the Seven Pilot Provinces/Municipalities). The new policies related to foreign-invested medical institutions are summarized in the following chart:

Different Foreign Investor Qualification Review Standards -Another Interesting Difference

Both Circular 109 and Circular 110 expressly stipulate that Taiwan, Hong Kong and Macao service providers applying to establish wholly foreign-owned hospitals in mainland China must "have direct or indirect experience in medical care investment and management and satisfy either of the following requirements: (1) they are able to provide any advanced hospital management experience, management model and service model; or (2) they are able to provide internationally leading medical technologies." Besides this, the Interim Measures also provide that "the Chinese and foreign parties to a joint venture medical institution or a cooperative medical institution shall have direct or indirect experience in medical and healthcare investment and management, and shall meet one of the following requirements: (1) they are able to provide internationally advanced managerial experience in managing medical institutions, modes of management and modes of services; (2) they are able to provide internationally cutting-edge medical technologies and equipment; or (3) they can complement or make up for the inadequacy of local medical service capacity, medical treatment technologies, funds and medical facilities."

We can see that, aside from the flexible "complement" condition that was added to the Interim Measures, all three laws require foreign investors to have direct or indirect experience in healthcare investment and management. However, although the requirement equally applies to joint-venture medical institutions, cooperative medical institutions and wholly foreign-owned medical institutions, review procedures for establishing these three forms of medical institutions are not the same. With respect to establishing joint venture medical institutions and cooperative medical institutions, it is not mandatory for foreign investors to submit materials evidencing they have direct or indirect experience in healthcare investment and management. However, with respect to wholly foreign-owned medical institutions, such materials are required to be submitted and will be strictly examined. Thus, foreign investors that do not have direct or indirect experience in medical care investment and management cannot establish wholly foreign-owned medical institutions in the name of Taiwan, Hong Kong and Macao investors. Such investors may, however, be able to set up joint venture medical institutions or contractual hospitals so long as their shareholding ratios do not exceeding 70%.

In addition to the differences in review standards among Circular 109, Circular 110 and the Interim Measures as mentioned above, different local authorities may in practice also have different requirements for the three different forms of medical institutions:

In addition to the basic review materials listed in the above table, local examination and approval authorities may require Taiwan, Hong Kong and Macao investors to provide additional documents to prove that they are service providers who engage in substantial business operations, such as the Profits Tax Returns and Notices of Assessment and Demand for Tax Payment for the last three years and Tax Returns for Salary and Pension of Employees in Hong Kong. With respect to qualifications for service providers, please refer to the CEPA and ECFA.

Regulations and policies related to foreign-invested medical institutions are still under development and are subject to the influence of the economic environment and macro policies. We will continually observe this issue. As the laws and regulations change, we also note some notable cases have arisen in judicial practice which we will discuss further in the next article.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

To print this article, all you need is to be registered on Mondaq.com.

Click to Login as an existing user or Register so you can print this article.

Authors
Similar Articles
Relevancy Powered by MondaqAI
 
Some comments from our readers…
“The articles are extremely timely and highly applicable”
“I often find critical information not available elsewhere”
“As in-house counsel, Mondaq’s service is of great value”

Related Topics
 
Similar Articles
Relevancy Powered by MondaqAI
Related Articles
 
Up-coming Events Search
Tools
Print
Font Size:
Translation
Channels
Mondaq on Twitter
 
Register for Access and our Free Biweekly Alert for
This service is completely free. Access 250,000 archived articles from 100+ countries and get a personalised email twice a week covering developments (and yes, our lawyers like to think you’ve read our Disclaimer).
 
Email Address
Company Name
Password
Confirm Password
Position
Mondaq Topics -- Select your Interests
 Accounting
 Anti-trust
 Commercial
 Compliance
 Consumer
 Criminal
 Employment
 Energy
 Environment
 Family
 Finance
 Government
 Healthcare
 Immigration
 Insolvency
 Insurance
 International
 IP
 Law Performance
 Law Practice
 Litigation
 Media & IT
 Privacy
 Real Estate
 Strategy
 Tax
 Technology
 Transport
 Wealth Mgt
Regions
Africa
Asia
Asia Pacific
Australasia
Canada
Caribbean
Europe
European Union
Latin America
Middle East
U.K.
United States
Worldwide Updates
Registration (you must scroll down to set your data preferences)

Mondaq Ltd requires you to register and provide information that personally identifies you, including your content preferences, for three primary purposes (full details of Mondaq’s use of your personal data can be found in our Privacy and Cookies Notice):

  • To allow you to personalize the Mondaq websites you are visiting to show content ("Content") relevant to your interests.
  • To enable features such as password reminder, news alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our content providers ("Contributors") who contribute Content for free for your use.

Mondaq hopes that our registered users will support us in maintaining our free to view business model by consenting to our use of your personal data as described below.

Mondaq has a "free to view" business model. Our services are paid for by Contributors in exchange for Mondaq providing them with access to information about who accesses their content. Once personal data is transferred to our Contributors they become a data controller of this personal data. They use it to measure the response that their articles are receiving, as a form of market research. They may also use it to provide Mondaq users with information about their products and services.

Details of each Contributor to which your personal data will be transferred is clearly stated within the Content that you access. For full details of how this Contributor will use your personal data, you should review the Contributor’s own Privacy Notice.

Please indicate your preference below:

Yes, I am happy to support Mondaq in maintaining its free to view business model by agreeing to allow Mondaq to share my personal data with Contributors whose Content I access
No, I do not want Mondaq to share my personal data with Contributors

Also please let us know whether you are happy to receive communications promoting products and services offered by Mondaq:

Yes, I am happy to received promotional communications from Mondaq
No, please do not send me promotional communications from Mondaq
Terms & Conditions

Mondaq.com (the Website) is owned and managed by Mondaq Ltd (Mondaq). Mondaq grants you a non-exclusive, revocable licence to access the Website and associated services, such as the Mondaq News Alerts (Services), subject to and in consideration of your compliance with the following terms and conditions of use (Terms). Your use of the Website and/or Services constitutes your agreement to the Terms. Mondaq may terminate your use of the Website and Services if you are in breach of these Terms or if Mondaq decides to terminate the licence granted hereunder for any reason whatsoever.

Use of www.mondaq.com

To Use Mondaq.com you must be: eighteen (18) years old or over; legally capable of entering into binding contracts; and not in any way prohibited by the applicable law to enter into these Terms in the jurisdiction which you are currently located.

You may use the Website as an unregistered user, however, you are required to register as a user if you wish to read the full text of the Content or to receive the Services.

You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these Terms or with the prior written consent of Mondaq. You may not use electronic or other means to extract details or information from the Content. Nor shall you extract information about users or Contributors in order to offer them any services or products.

In your use of the Website and/or Services you shall: comply with all applicable laws, regulations, directives and legislations which apply to your Use of the Website and/or Services in whatever country you are physically located including without limitation any and all consumer law, export control laws and regulations; provide to us true, correct and accurate information and promptly inform us in the event that any information that you have provided to us changes or becomes inaccurate; notify Mondaq immediately of any circumstances where you have reason to believe that any Intellectual Property Rights or any other rights of any third party may have been infringed; co-operate with reasonable security or other checks or requests for information made by Mondaq from time to time; and at all times be fully liable for the breach of any of these Terms by a third party using your login details to access the Website and/or Services

however, you shall not: do anything likely to impair, interfere with or damage or cause harm or distress to any persons, or the network; do anything that will infringe any Intellectual Property Rights or other rights of Mondaq or any third party; or use the Website, Services and/or Content otherwise than in accordance with these Terms; use any trade marks or service marks of Mondaq or the Contributors, or do anything which may be seen to take unfair advantage of the reputation and goodwill of Mondaq or the Contributors, or the Website, Services and/or Content.

Mondaq reserves the right, in its sole discretion, to take any action that it deems necessary and appropriate in the event it considers that there is a breach or threatened breach of the Terms.

Mondaq’s Rights and Obligations

Unless otherwise expressly set out to the contrary, nothing in these Terms shall serve to transfer from Mondaq to you, any Intellectual Property Rights owned by and/or licensed to Mondaq and all rights, title and interest in and to such Intellectual Property Rights will remain exclusively with Mondaq and/or its licensors.

Mondaq shall use its reasonable endeavours to make the Website and Services available to you at all times, but we cannot guarantee an uninterrupted and fault free service.

Mondaq reserves the right to make changes to the services and/or the Website or part thereof, from time to time, and we may add, remove, modify and/or vary any elements of features and functionalities of the Website or the services.

Mondaq also reserves the right from time to time to monitor your Use of the Website and/or services.

Disclaimer

The Content is general information only. It is not intended to constitute legal advice or seek to be the complete and comprehensive statement of the law, nor is it intended to address your specific requirements or provide advice on which reliance should be placed. Mondaq and/or its Contributors and other suppliers make no representations about the suitability of the information contained in the Content for any purpose. All Content provided "as is" without warranty of any kind. Mondaq and/or its Contributors and other suppliers hereby exclude and disclaim all representations, warranties or guarantees with regard to the Content, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. To the maximum extent permitted by law, Mondaq expressly excludes all representations, warranties, obligations, and liabilities arising out of or in connection with all Content. In no event shall Mondaq and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use of the Content or performance of Mondaq’s Services.

General

Mondaq may alter or amend these Terms by amending them on the Website. By continuing to Use the Services and/or the Website after such amendment, you will be deemed to have accepted any amendment to these Terms.

These Terms shall be governed by and construed in accordance with the laws of England and Wales and you irrevocably submit to the exclusive jurisdiction of the courts of England and Wales to settle any dispute which may arise out of or in connection with these Terms. If you live outside the United Kingdom, English law shall apply only to the extent that English law shall not deprive you of any legal protection accorded in accordance with the law of the place where you are habitually resident ("Local Law"). In the event English law deprives you of any legal protection which is accorded to you under Local Law, then these terms shall be governed by Local Law and any dispute or claim arising out of or in connection with these Terms shall be subject to the non-exclusive jurisdiction of the courts where you are habitually resident.

You may print and keep a copy of these Terms, which form the entire agreement between you and Mondaq and supersede any other communications or advertising in respect of the Service and/or the Website.

No delay in exercising or non-exercise by you and/or Mondaq of any of its rights under or in connection with these Terms shall operate as a waiver or release of each of your or Mondaq’s right. Rather, any such waiver or release must be specifically granted in writing signed by the party granting it.

If any part of these Terms is held unenforceable, that part shall be enforced to the maximum extent permissible so as to give effect to the intent of the parties, and the Terms shall continue in full force and effect.

Mondaq shall not incur any liability to you on account of any loss or damage resulting from any delay or failure to perform all or any part of these Terms if such delay or failure is caused, in whole or in part, by events, occurrences, or causes beyond the control of Mondaq. Such events, occurrences or causes will include, without limitation, acts of God, strikes, lockouts, server and network failure, riots, acts of war, earthquakes, fire and explosions.

By clicking Register you state you have read and agree to our Terms and Conditions